PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9020878-0	1997	Neuropeptide Y modulates ATP-induced increases in internal calcium via the adenylate cyclase/protein kinase A system in a human neuroblastoma cell line.	Adenosine Triphosphate	25-28	neuropeptide Y	Homo sapiens	0-14	
9020878-0	1997	Neuropeptide Y modulates ATP-induced increases in internal calcium via the adenylate cyclase/protein kinase A system in a human neuroblastoma cell line.	Calcium	59-66	neuropeptide Y	Homo sapiens	0-14	
9020878-1	1997	The modulatory effects of neuropeptide Y (NPY) on ATP-induced increases in cytosolic free-calcium concentration ([Ca2+]i) were investigated in the CHP-234 human neuroblastoma cell line.	Adenosine Triphosphate	50-53	neuropeptide Y	Homo sapiens	42-45	
9020878-1	1997	The modulatory effects of neuropeptide Y (NPY) on ATP-induced increases in cytosolic free-calcium concentration ([Ca2+]i) were investigated in the CHP-234 human neuroblastoma cell line.	Calcium	90-97	neuropeptide Y	Homo sapiens	42-45	
9020878-2	1997	Pretreatment of cells with 100 nM NPY potentiated the increase in [Ca2+]i evoked subsequently by 20 microM ATP, compared with initial application of ATP in a control experiment, whereas a similar pretreatment with 1 microM NPY attenuated the subsequent response to ATP.	Adenosine Triphosphate	107-110	neuropeptide Y	Homo sapiens	34-37	
9020878-2	1997	Pretreatment of cells with 100 nM NPY potentiated the increase in [Ca2+]i evoked subsequently by 20 microM ATP, compared with initial application of ATP in a control experiment, whereas a similar pretreatment with 1 microM NPY attenuated the subsequent response to ATP.	Adenosine Triphosphate	149-152	neuropeptide Y	Homo sapiens	34-37	
9020878-2	1997	Pretreatment of cells with 100 nM NPY potentiated the increase in [Ca2+]i evoked subsequently by 20 microM ATP, compared with initial application of ATP in a control experiment, whereas a similar pretreatment with 1 microM NPY attenuated the subsequent response to ATP.	Adenosine Triphosphate	149-152	neuropeptide Y	Homo sapiens	34-37	
9020878-3	1997	Both actions of NPY were completely blocked by H-89 [N-[2-((3-(4-bromo-phenyl)-2-propenyl)-amino)-ethyl]-5 isoquinoline sulphonamide dihydrochloride], a selective antagonist of protein kinase A.	n-[2-((3-(4-bromo-phenyl)-2-propenyl	53-89	neuropeptide Y	Homo sapiens	16-19	
9020878-3	1997	Both actions of NPY were completely blocked by H-89 [N-[2-((3-(4-bromo-phenyl)-2-propenyl)-amino)-ethyl]-5 isoquinoline sulphonamide dihydrochloride], a selective antagonist of protein kinase A.	-amino)-ethyl]-5 isoquinoline sulphonamide dihydrochloride	90-148	neuropeptide Y	Homo sapiens	16-19	
9020878-4	1997	The effects of 100 nM NPY were mimicked by H-89, while forskolin and 8-Br-cAMP mimicked the effects of 1 microM NPY.	Colforsin	55-64	neuropeptide Y	Homo sapiens	112-115	
9020878-4	1997	The effects of 100 nM NPY were mimicked by H-89, while forskolin and 8-Br-cAMP mimicked the effects of 1 microM NPY.	8-Bromo Cyclic Adenosine Monophosphate	69-78	neuropeptide Y	Homo sapiens	112-115	
9020878-5	1997	Both basal and forskolin-stimulated cAMP levels were inhibited by 100 nM NPY and by 100 nM NPY(13-36), a selective agonist of the NPY Y2-receptor subtype.	Colforsin	15-24	neuropeptide Y	Homo sapiens	73-76	
9020878-5	1997	Both basal and forskolin-stimulated cAMP levels were inhibited by 100 nM NPY and by 100 nM NPY(13-36), a selective agonist of the NPY Y2-receptor subtype.	Colforsin	15-24	neuropeptide Y	Homo sapiens	91-94	
9020878-5	1997	Both basal and forskolin-stimulated cAMP levels were inhibited by 100 nM NPY and by 100 nM NPY(13-36), a selective agonist of the NPY Y2-receptor subtype.	Colforsin	15-24	neuropeptide Y receptor Y2	Homo sapiens	130-145	
9020878-5	1997	Both basal and forskolin-stimulated cAMP levels were inhibited by 100 nM NPY and by 100 nM NPY(13-36), a selective agonist of the NPY Y2-receptor subtype.	Cyclic AMP	36-40	neuropeptide Y	Homo sapiens	73-76	
9020878-5	1997	Both basal and forskolin-stimulated cAMP levels were inhibited by 100 nM NPY and by 100 nM NPY(13-36), a selective agonist of the NPY Y2-receptor subtype.	Cyclic AMP	36-40	neuropeptide Y	Homo sapiens	91-94	
9020878-5	1997	Both basal and forskolin-stimulated cAMP levels were inhibited by 100 nM NPY and by 100 nM NPY(13-36), a selective agonist of the NPY Y2-receptor subtype.	Cyclic AMP	36-40	neuropeptide Y receptor Y2	Homo sapiens	130-145	
9020878-7	1997	It is concluded that NPY has a biphasic modulatory effect on increases in [Ca2+]i produced by ATP, which probably involves the cAMP/protein kinase A cascade.	Adenosine Triphosphate	94-97	neuropeptide Y	Homo sapiens	21-24